WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Quintiles Transnational Corp., a global leader in pharmaceutical services, has signed a multi-year license agreement to extend its use of Phase Forward’s InForm™ electronic data capture solution for clinical trials. Phase Forward’s InForm solution has been used in nearly 90 percent of all Quintiles EDC trials to date, and will continue to be a technology on which Quintiles provides services to its customers.
